Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: RON BL who wrote (458152)	9/13/2003 12:33:59 AM
From: Lizzie Tudor	Read Replies (1) \| Respond to of 769667

Then say good by to the Biotech future and kiss all those cancer cures goodbye. Oh boo hoo. Woe is me. Look- I now have to present an offshoring strategy in business plans I want to pass by VCs. My dept, which is pretty state of the art supply chain software, is now 99.9% operating out of india with one exception (me). Why? Free market, of course. US labor too expensive, blah blah. Unfortunately we are losing expertise in optical networking, collaboration software, you name it. I'm not interested in any BS lines the republicans dish out about "losing" the biotech industry. Dump it, I say. If they can't compete tough. And that goes for the iraq contracts too. Open em up to the free market, take the lowest bidder. Probably poland.

To: RON BL who wrote (458152)	9/13/2003 12:38:48 AM
From: Richard S	Read Replies (2) \| Respond to of 769667

Ron What are you talking about? The problem with the drug industry is lack of competition. These companies continue to renew their patents and control the markets on drugs even once the patents expire. Opening markets has nothing to do with who develops the medications, it is a question of greed on the part of the pharmaceutical companies to go beyond the periods they are entitled to control their patents without competition. It doesn't make sense to me that the drugs are sold to other countries at cheaper prices while the US has to continue to pay high prices for the drugs. A more equitable solution needs to be reached.